EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 19 / No 11 (Novembre 2003) Med Sci (Paris), 19 11 (2003) 1121-1127 References
Free Access
Issue
Med Sci (Paris)
Volume 19, Number 11, Novembre 2003
Page(s) 1121 - 1127
Section M/S Revues
DOI https://doi.org/10.1051/medsci/200319111121
Published online 15 November 2003
  1. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocrinol Rev 1999; 20: 435–59. [Google Scholar]
  2. McKay LI, Cidlowski JA. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors:mechanisms of mutual antagonism. Mol Endocrinol 1998; 12: 45–56. [Google Scholar]
  3. Auphan N, DiDonato JA, Rosette C, Helmberg A,Karin M.Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995; 270: 286–90. [Google Scholar]
  4. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA,Baldwin AS Jr.Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.Mol Cell Biol 1995;15: 943–53. [Google Scholar]
  5. Schouten GJ, van der Eb AJ, Zantema A. Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A. EMBO J 1995; 14: 1498–507. [Google Scholar]
  6. Heck S, Bender K, Kullmann M, et al. I kappaB alpha-independent downregulation of NF-kappa B activity by glucocorticoid receptor. EMBO J 1997; 16: 4698–707. [Google Scholar]
  7. Brostjan C, Anrather J, Csizmadia V, et al.Glucocorticoid-mediated repression of NF-kappa B activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem 1996;271: 19612–6. [Google Scholar]
  8. De Bosscher K, Vanden Berghe W, Haegeman G. Mechanisms of antiinflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 2000;109: 16–22. [Google Scholar]
  9. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752–6. [Google Scholar]
  10. Baes M, Castelein H, Desmet L, Declercq PE. Antagonism of COUP-TF and PPAR alpha/RXR alpha on the activation of the malic enzyme gene promoter:modulation by 9-cis RA. Biochem Biophys Res Commun 1995;215: 338–45. [Google Scholar]
  11. Ikeda Y, Sugawara A, Taniyama Y, et al.Suppression of rat thromboxane synthase gene transcription by peroxisome proliferatoractivated receptor gamma in macrophages via an interaction with NRF2. J Biol Chem 2000;275: 33142–50. [Google Scholar]
  12. Sheppard KA, Phelps KM, Williams AJ, et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappa B signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 1998;273: 29291–4. [Google Scholar]
  13. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.Cell 1996; 85: 403–14 [Google Scholar]
  14. McKay LI, Cidlowski JA. CBP (CREB binding protein)integrates NF-kappa B (nuclear factor-kappa B)and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000; 14: 1222–34. [Google Scholar]
  15. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 2001; 98: 6865–70. [Google Scholar]
  16. Supakar PC, Jung MH, Song CS, Chatterjee B, Roy AK. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the agedependent desensitization of the liver. J Biol Chem 1995; 270: 837–42. [Google Scholar]
  17. Kalkhoven E, Wissink S, van der Saagn PT, van der Burg B. Negative interaction between the RelA(p65)subunit of NF-kappa B and the progesterone receptor. J Biol Chem 1996;271: 6217–24. [Google Scholar]
  18. Ray P, Ghosh SK, Zhang DH, Ray A. Repression of interleukin-6 gene expression by 17 betaestradiol:inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett 1997; 409: 79–85. [Google Scholar]
  19. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15: 4971–9. [Google Scholar]
  20. Staels B, Koenig W, Habib A, et al. Activation of human aortic smoothmuscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998; 393: 790–3. [Google Scholar]
  21. Delerive P, De Bosscher K, Besnard S, et al.Peroxisome proliferatoractivated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NFkappaB and AP-1. J Biol Chem 1999;274: 32048–54. [Google Scholar]
  22. Hansen LA, Sigman CC, Andreola F, et al. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000;21: 1271–9. [Google Scholar]
  23. Darby TG, Meissner JD, Ruhlmann A, Mueller WH, Scheibe RJ. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene 1997;15: 3067–82. [Google Scholar]
  24. Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell 1991;66: 831–4. [Google Scholar]
  25. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266–72. [Google Scholar]
  26. Schule R, Rangarajan P, Yang N, et al. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc Natl Acad Sci USA 1991; 88: 6092–6. [Google Scholar]
  27. Schule R, Evans RM. Crosscoupling of signal transduction pathways:zinc finger meets leucine zipper. Trends Genet 1991;7: 377–81. [Google Scholar]
  28. Jonat C, Rahmsdorf HJ, Park KK, et al. Antitumor promotion and antiinflammation: downmodulation of AP-1(Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189–204. [Google Scholar]
  29. Yang-Yen HF, Chambard JC, Sun YL, et al. Transcriptional interference between c-Jun and the glucocorticoid receptor:mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;2: 1205–15. [Google Scholar]
  30. Nicholson RC, Mader S, Nagpal S, et al. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 1990;9: 4443–54. [Google Scholar]
  31. Zhang XK, Wills KN, Husmann M, Hermann T, Pfahl M. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 1991; 11: 6016–25. [Google Scholar]
  32. Doucas V, Spyrou G, Yaniv M. Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO J 1991;10: 2237–45. [Google Scholar]
  33. Schule R, Umesono K, Mangelsdorf DJ, et al. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 1990; 61: 497–504. [Google Scholar]
  34. Lucibello FC, Slater EP, Jooss KU, Beato M, Muller R. Mutual transrepression of Fos and the glucocorticoid receptor:involvement of a functional domain in Fos which is absent in FosB. EMBO J 1990; 9: 2827–34. [Google Scholar]
  35. Wagner S, Green MR. DNA-binding domains: targets for viral and cellular regulators. Curr Opin Cell Biol 1994; 6: 410–4. [Google Scholar]
  36. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev 1999; 13: 1398–411. [Google Scholar]
  37. Zhang P, Behre G, Pan J, et al. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc Natl Acad Sci USA 1999; 96: 8705–10. [Google Scholar]
  38. Nerlov C, Querfurth E, Kulessa H, Graf T. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 2000; 95: 2543–51. [Google Scholar]
  39. Lee SK, Kim HJ, Na SY, et al. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem 1998; 273: 16651–4. [Google Scholar]
  40. De Bosscher K, Vanden Berghe W, Haegeman G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol Endocrinol 2001; 15: 219–27. [Google Scholar]
  41. Zhou XF, Shen XQ, Shemshedini L. Ligandactivated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol Endocrinol 1999; 13: 276–85. [Google Scholar]
  42. Caelles C, Gonzalez-Sancho JM, Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 1997; 11: 3351–64. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.